1 |
1984 |
East |
Red Sea |
Cross-sectional hospital-based |
ELISA-IgM |
100 |
21 |
21% |
DENV1 and 2 |
- |
M + F |
[23] |
2 |
1988 |
Central |
Khartoum |
Cross-sectional hospital-based |
ELISA-IgG |
196 |
97 |
33% |
DENV2 |
20 |
M + F |
[11] |
3 |
1989 |
North |
Northern |
Cross-sectional hospital-based |
ELISA-IgG |
185 |
44 |
24% |
DENV2 |
34 |
M + F |
[12] |
4 |
2000 |
Central |
Khartoum |
Cross-sectional community-based |
ELISA-IgM |
1157 |
485 |
42% |
- |
- |
M + F |
[24] |
5 |
2005 |
East |
Red Sea |
Cross-sectional hospital-based |
ELISA-IgM |
312 |
36 |
12% |
DENV3 |
5–15 |
M + F |
[10] |
6 |
2009 |
East |
Red Sea |
Retrospective Cohort |
ELISA-IgM |
10,820 |
78 |
1% |
- |
- |
Pregnant women |
[25] |
7 |
2009 |
East |
Red Sea |
Cross-sectional community-based |
ELISA-IgM |
791 |
41 |
5.2% |
- |
30 |
M + F |
[26] |
8 |
2010 |
East |
Kassala |
Cross-sectional hospital-based |
ELISA-IgM |
113 |
81 |
72% |
- |
25.5 |
M + F |
[27] |
9 |
2010 |
East |
Red Sea |
Cross-sectional hospital-based |
ELISA-IgM |
200 |
73 |
37% |
DENV2–4 |
25 |
M + F |
[9] |
10 |
2011 |
East |
Kassala |
Cross-sectional community-based |
ELISA-IgM |
491 |
46 |
9% |
- |
40 |
M + F |
[28] |
11 |
2012 |
East |
Kassala |
Cross-sectional hospital-based |
ELISA-IgM |
275 |
17 |
6% |
- |
17.8 |
M + F |
[29] |
12 |
2012 |
East |
Red Sea |
Cross-sectional hospital-based |
ELISA-IgM |
130 |
9 |
7% |
- |
- |
F |
[30] |
13 |
2012 |
East |
Red Sea |
Cross-sectional hospital-based |
ELISA-IgM |
39 |
5 |
13% |
- |
26 |
Pregnant women |
[31] |
14 |
2012 |
West |
South Kordofan |
Cross-sectional community-based |
ELISA-IgG |
615 |
170 |
28% |
- |
37.5 |
M + F |
[32] |
15 |
2013 |
East and West |
Red Sea, Kassala, North Kordofan |
Cross-sectional hospital-based |
ELISA-IgM |
483 |
302 |
63% |
DENV1–4 |
40.7 |
M + F |
[33] |
16 |
2015 |
West |
North Darfur |
Cross-sectional hospital-based |
ELISA-IgG |
50 |
35 |
70% |
DENV1 and 3 |
37.8 |
M + F |
[14] |
17 |
2016 |
West |
Central, North, South, and West Darfur |
Cross-sectional hospital-based |
ELISA-IgM |
204 |
32 |
16% |
DENV1 and 3 |
- |
M + F |
[13] |
18 |
2017 |
East |
Gadaref |
Cross-sectional community-based |
ELISA-IgG |
701 |
334 |
48% |
- |
- |
M + F |
[34] |
19 |
2017 |
East |
Kassala |
Cross-sectional hospital-based |
RT-PCR |
106 |
4 |
4% |
DENV2 |
- |
- |
[18] |